Mycobacterium kansasii infection in patients infected with the human immunodeficiency virus

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 18, Issue 8, 1999, Pages 582-586

  Pintado, V ^a   Gomez Mampaso E ^a   Martin Davila P ^a   Cobo, J ^a   Navas, E ^a   Quereda, C ^a   Fortun J ^a   Guerrero, A ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; ETHAMBUTOL; ISONIAZID; OFLOXACIN; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; BACTERIAL COLONIZATION; CLINICAL ARTICLE; DRUG ABUSE; FEMALE; FEVER; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; LUNG DISEASE; LUNG INFECTION; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM KANSASII; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SIDE EFFECT;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-BACTERIAL AGENTS; ANTITUBERCULAR AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM KANSASII; PROGNOSIS; RETROSPECTIVE STUDIES; SPAIN; SPUTUM; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0002595494     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960050351     Document Type: Article

References (14)

1. 1. Centers for Disease Control: Diagnosis and management of mycobacterial infection and disease in persons with human immunodeficiency virus infection. Annals of Internal Medicine (1987) 106:254-256
2. 2. French AL, Benator DA, Gordin FM: Nontuberculous mycobacterial infections. Medical Clinics of North America (1997) 81:361-379
3. 3. Sherer R, Sable R, Sonnenberg M, Cooper S, Spencer P, Schwimmer S, Kocka F, Muthuswamy P, Kallick C: Disseminated infection with Mycobacterium kansasii in the acquired immunodeficiency syndrome. Annals of Internal Medicine (1986) 105:710-712
4. 4. Levine B, Chaisson RE: Mycobacterium kansasii: a cause of treatable pulmonary disease associated with advanced human immunodeficiency virus (HIV) infection. Annals of Internal Medicine (1991) 114:861-868
5. 5. Bamberger DM, Driks MR, Gupta MR, O'Connor MC, Jost PM, Neihart RE, McKinsey DS, Moore LA: Mycobacterium kansasii among patients infected with human immunodeficiency virus in Kansas City. Clinical Infectious Diseases (1994) 18:395-400
6. 6. Witzig RS, Fazal BA, Mera RM, Mushatt DM, Dejace PM, Greer DL, Hyslop NE Jr: Clinical manifestations and implications of coinfection with Mycobacterium kansasii and human immunodeficiency virus type 1. Clinical Infectious Diseases (1995) 21:77-85
7. 7. Carpenter JL, Parks JM: Mycobacterium kansasii infections in patients positive for human immunodeficiency virus. Reviews of Infectious Diseases (1991)13:789-796
8. 8. Campo RE, Campo CE: Mycobacterium kansasii disease in patients infected with human immunodeficiency virus. Clinical Infectious Diseases (1997) 24:1233-1238
9. 9. Urkijo JC, Montejo M, Aguirrebengoa K, Urra E, Aguirre C: Enfermedad por Mycobacterium kansasii en pacientes con infección por VIH. Enfermedades Infecciosas y Microbiología Clínica (1993) 11:120-125
10. 10. Boudon P, Le Pennec MP, Malbec D, Mathieu M, Slama JL, Manet P, Pines E, Kretz S, Giacomini T: Infection à Mycobacterium kansasii chez des patients infectés par le virus l'immunodeficiencie humaine. Revue de Medicine Interne (1995) 16:747-751
11. 11. Rooney G, Nelson MR, Gazzard B: Mycobacterium kansasii: its presentation, treatment and outcome in HIV infected patients. Journal of Clinical Pathology (1996) 49:821-823
12. 12. Centers for Disease Control: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbidity and Mortality Weekly Report (1992) 41 (RR-17):1-19
13. 13. Ahn CH, McLarty JW, Ahn SS, Ahn SI, Hurst GA: Diagnostic criteria for pulmonary disease caused by Mycobacterium kansasii and Mycobacterium intracellulare. American Review of Respiratory Disease (1982) 125:388-391
14. 14. Wallace RJ Jr, Dunbar D, Brown BA, Onyi G, Dunlap R, Ahn CH, Murphy DT: Rifampin-resistant Mycobacterium kansasii. Clinical Infectious Diseases (1994) 18:736-743